Výsledky vyhledávání - "Blanca García-Magallón"

Akademický článek

REDOSER project: optimising biological therapy dose for rheumatoid arthritis and spondyloarthritis patients

Autor: Isidoro González-Álvaro, Antonio J. Blasco, Pablo Lázaro, Carlos Sánchez-Piedra, Raquel Almodovar, Javier Bachiller-Corral, Alejandro Balsa, Rafael Caliz, Gloria Candelas, Cristina Fernández-Carballido, Angel García-Aparicio, Blanca García-Magallón, Rosario García-Vicuña, Antonio Gómez-Centeno, Ana M. Ortiz, Raimon Sanmartí, Jesús Sanz, Beatriz Tejera

Publikováno v: Heliyon, Vol 3, Iss 11, Pp e00452- (2017)

Background: Reducing the dose of biological therapy (BT) when patients with immune-mediated arthritis achieve a sustained therapeutic goal may help to decrease costs for national health services and reduce the risk of serious infection. However, ther

Externí odkaz: https://doaj.org/article/adf35f398f4c46c3a235bc59a928f91f

Zobrazit plný text záznamu

Akademický článek

Real-world effectiveness and safety of combined calcium 600 mg and cholecalciferol 2000 IU for treating vitamin D deficiency: Results from a nationwide study with focus in osteoporosis

Autor: Rosa Pinto-Bonilla, José Baeza-Noci, Clara Casado Blanco, Guillermo Javier Valls Gumbau, Rubén Juarez Fernández, María Pascual-Pastor, Blanca García Magallón, Blanca Panero Lamothe, Carmen Moragues Pastor, Rafael Izquierdo Aviñó, Eva García Aguilar, Paula Saz-Leal

Publikováno v: Bone Reports, Vol 22, Iss , Pp 101796- (2024)

Introduction: Treatment of calcium (Ca) and vitamin D (VD) deficiency (VDD) is crucial for health, especially in bone conditions, such as low bone mineral density (BMD) and osteoporosis. Despite updates in clinical guideline recommendations, no studi

Externí odkaz: https://doaj.org/article/195275b70b91497ebbf0637b0a5951b3

Zobrazit plný text záznamu

Validation of screening criteria for spondyloarthritis in patients with inflammatory bowel disease in routine clinical practice

Autor: Fernando Gomollón, Daniel Seoane-Mato, Miguel A. Montoro, Xavier Juanola, Elisa Trujillo-Martin, Marta Carrillo-Palau, Virginia Matallana, Blanca García-Magallón, Yolanda Ber, Laura Ramos, Eva Perez-Pampin, Rocío Ferreiro-Iglesias, Lorena Rodríguez-Alonso, Carla Marco-Pascual, Jesús Sanz Sanz

Publikováno v: Digestive and Liver Disease. 54:755-762

Spondyloarthritis (SpA) is one of the most common extraintestinal manifestations of inflammatory bowel disease (IBD). Diagnostic delay must be avoided.We assessed the validity of SpA screening criteria (any of the following characteristics: chronic l

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::17c39a53640ccd2bb7b5a43a47adc645
https://doi.org/10.1016/j.dld.2021.12.010

Zobrazit plný text záznamu

Prevalence and factors associated with osteoporosis and fragility fractures in patients with primary Sjogren syndrome

Publikováno v: Rheumatology International
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
instname
RHEUMATOLOGY INTERNATIONAL
r-FISABIO. Repositorio Institucional de Producción Científica
r-FISABIO: Repositorio Institucional de Producción Científica
Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (FISABIO)
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
r-ISABIAL. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica y Sanitaria de Alicante

This study aimed at determining socio-demographic and clinical factors of primary Sjögren syndrome (pSS) associated with osteoporosis (OP) and fragility fracture. SJOGRENSER is a cross-sectional study of patients with pSS, classified according to Am

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::149497a3ba76d0b8d26b20185794712e
https://fundanet.igtp.cat/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=4384

Zobrazit plný text záznamu

REDOSER project: optimising biological therapy dose for rheumatoid arthritis and spondyloarthritis patients

Autor: Raimon Sanmartí, Javier Bachiller-Corral, Isidoro González-Álvaro, Blanca García-Magallón, Gloria Candelas, Ana M. Ortiz, Carlos Sánchez-Piedra, B. Tejera, Antonio Javier Blasco, Alejandro Balsa, Cristina Fernández-Carballido, Raquel Almodóvar, Angel García-Aparicio, Antonio Gómez-Centeno, Pablo Lázaro, Rafael Cáliz, Jesús Sanz, Rosario García-Vicuña

Publikováno v: Heliyon, Vol 3, Iss 11, Pp e00452-(2017)
Repositorio Institucional de la Consejería de Sanidad de la Comunidad de Madrid
Consejería de Sanidad de la Comunidad de Madrid
Heliyon

Background Reducing the dose of biological therapy (BT) when patients with immune-mediated arthritis achieve a sustained therapeutic goal may help to decrease costs for national health services and reduce the risk of serious infection. However, there

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::36f8f0cacd14acd40bb89aedd9535e15
http://www.sciencedirect.com/science/article/pii/S2405844017310150

Zobrazit plný text záznamu

Longitudinal practice patterns of prophylaxis of glucocorticoid-induced osteoporosis in patients with polymyalgia rheumatica

Autor: Mercedes Jiménez-Palop, Antonio Naranjo, Laura Cáceres, Ruben Quesada Lopez, F. Francisco, Blanca García-Magallón, Soledad Ojeda-Bruno

Publikováno v: Rheumatology International. 34:1459-1463

The aim of this study was to analyze the longitudinal practice patterns of prophylaxis of glucocorticoid-induced osteoporosis in patients with polymyalgia rheumatica (PMR). Patients diagnosed with PMR were collected retrospectively in two rheumatolog

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6d48c460fcf5de1bedaddf5c9e603938
https://doi.org/10.1007/s00296-014-3014-2

Zobrazit plný text záznamu

Update on the Use of Steroids in Rheumatoid Arthritis

Autor: Blanca García-Magallón, Lucía Silva-Fernández, Jose Luis Andreu-Sanchez

Publikováno v: Reumatología Clínica (English Edition). 9:297-302

Corticosteroids are a mainstay in the therapy of rheumatoid arthritis (RA). In recent years, a number of high-quality controlled clinical trials have shown their effect as a disease-modifying anti-rheumatic drug (DMARD) and a favorable safety profile

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9171cfd623ccf71ac36578a3df038757
https://doi.org/10.1016/j.reumae.2013.01.015

Zobrazit plný text záznamu

Actualización del uso de los glucocorticoides en la artritis reumatoide

Autor: Blanca García-Magallón, Jose Luis Andreu-Sanchez, Lucía Silva-Fernández

Publikováno v: Reumatología Clínica. 9:297-302

Los glucocorticoides son un componente fundamental en el tratamiento de la artritis reumatoide (AR). En los ultimos anos, numerosos ensayos clinicos controlados de alta calidad metodologica han demostrado su accion como farmaco antirreumatico modific

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::4234833803fc679744a2db601a67243b
https://doi.org/10.1016/j.reuma.2013.01.010

Zobrazit plný text záznamu

Artritis séptica por Scedosporium apiospermum de lenta instauración tras infiltración periarticular

Autor: Beatriz Orden Martínez, Mónica Fernández Castro, Antonio Ramos Martínez, Jessica Polo Laborda, Manuel Navarro, Carlos Ortega Sánchez, Blanca García Magallón

Publikováno v: Revista Iberoamericana de Micología. 29:241-244

BACKGROUND: Fungal arthritis is usually of haematogenous origin, and mainly affects patients with impaired cellular immunity or users of intravenous drugs. The infection in immunocompetent patients is generally caused by direct inoculation of the mic

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::2e57276f45daa5013226d18b745454cd
https://doi.org/10.1016/j.riam.2012.02.001

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání